Trials / Completed
CompletedNCT04014842
RapidShock Post-Approval Study
Post-Approval Study for Reconfirmation Analysis Mode Algorithm
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,756 (actual)
- Sponsor
- Zoll Medical Corporation · Industry
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Not accepted
Summary
Compare the performance of the Reconfirmation Analysis Mode algorithm to the performance goals recommended by the American Heart Association.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RapidShock | Use of the Reconfirmation Analysis Mode algorithm |
Timeline
- Start date
- 2019-02-26
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2019-07-10
- Last updated
- 2024-07-23
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04014842. Inclusion in this directory is not an endorsement.